Abstract
Fatty acid biosynthesis is essential for bacterial survival. In recent years, components of this biosynthetic pathway have aroused wide concern. β-Ketoacyl-acyl carrier protein synthase III (FabH) is a particularly attractive target which catalyzes the initial step of fatty acid biosynthesis. In this review, fatty acid biosynthesis, recent advances in the research of FabH as well as related inhibitors are reviewed. Finally, we also discuss the prospect and developmental trend of FabH inhibitors as anti-bacterial agents.
Keywords: anti-bacterial agents, fatty acid synthase (FAS), FabH, FabH inhibitors, Alkyl-CoA disulfides, Thiolactomycin derivatives, 1,2-Dithiole-3-(thi)ones derivatives, Dithiole-3-(thi)ones derivatives, Cerulenin derivatives, Indole derivatives, Benzoylaminobenzoic acid derivatives, Alkylsulfonyl derivatives, Thiazolidine-2-one 1, 1-dioxide derivatives
Current Medicinal Chemistry
Title: Advances in the Research of β-Ketoacyl-ACP Synthase III (FabH) Inhibitors
Volume: 19 Issue: 8
Author(s): H. -J. Zhang, Z. -L. Li and H. -L. Zhu
Affiliation:
Keywords: anti-bacterial agents, fatty acid synthase (FAS), FabH, FabH inhibitors, Alkyl-CoA disulfides, Thiolactomycin derivatives, 1,2-Dithiole-3-(thi)ones derivatives, Dithiole-3-(thi)ones derivatives, Cerulenin derivatives, Indole derivatives, Benzoylaminobenzoic acid derivatives, Alkylsulfonyl derivatives, Thiazolidine-2-one 1, 1-dioxide derivatives
Abstract: Fatty acid biosynthesis is essential for bacterial survival. In recent years, components of this biosynthetic pathway have aroused wide concern. β-Ketoacyl-acyl carrier protein synthase III (FabH) is a particularly attractive target which catalyzes the initial step of fatty acid biosynthesis. In this review, fatty acid biosynthesis, recent advances in the research of FabH as well as related inhibitors are reviewed. Finally, we also discuss the prospect and developmental trend of FabH inhibitors as anti-bacterial agents.
Export Options
About this article
Cite this article as:
-J. Zhang H., -L. Li Z. and -L. Zhu H., Advances in the Research of β-Ketoacyl-ACP Synthase III (FabH) Inhibitors, Current Medicinal Chemistry 2012; 19 (8) . https://dx.doi.org/10.2174/092986712799320484
DOI https://dx.doi.org/10.2174/092986712799320484 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Current Nanomedicine Editorial: MRI of the Small Bowel
Current Medical Imaging A Pathogenetic Approach to Autoimmune Skin Disease Therapy: Psoriasis and Biological Drugs, Unresolved Issues, and Future Directions
Current Pharmaceutical Design Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors
Current Cancer Drug Targets Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Reference Database of Lung Volumes and Capacities in Wistar Rats from 2 to 24 Months
Current Aging Science Autonomic Nervous System Alterations in Rett Syndrome
Current Pediatric Reviews Current and Under Development Treatment Modalities of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets RNAi Applications in Therapy Development for Neurodegenerative Disease
Current Pharmaceutical Design Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine Post-stroke Engagement-sensitive Balance Rehabilitation Under An Adaptive Multi-level Electrotherapy: Clinical Hypothesis and Computational Framework
Neuroscience and Biomedical Engineering (Discontinued) Multimodality Imaging in Acute Ischemic Stroke
Current Medical Imaging In-Vitro and In-Vivo Pharmacological Activities with Phytochemical Evaluation of Methanolic Extract of Microcos paniculata Stem Barks
Current Drug Therapy Adenosine and Related Drugs in Brain Diseases: Present and Future in Clinical Trials
Current Topics in Medicinal Chemistry Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
Recent Patents on Anti-Infective Drug Discovery Transient Tachypnea of the Newborn: The Treatment Strategies
Current Pharmaceutical Design Zinc Supplementation in Preterm Neonates with Jaundice: Is it Beneficial?
Endocrine, Metabolic & Immune Disorders - Drug Targets Visual Event-Related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease: A Literature Review
Current Alzheimer Research Regulation of Intestinal Barrier Function by Dietary Polyphenols
Current Nutrition & Food Science Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials
CNS & Neurological Disorders - Drug Targets